PR89159

EAST FALMOUTH, Mass., April 24, 2021 /PRNewswire=KYODO JBN/ --

Associates of Cape Cod, Inc. (ACC), a Seikagaku Group Company, announces the

launch of a new, innovative, sustainable recombinant LAL reagent, PyroSmart

NextGen(TM) for Bacterial Endotoxin Testing (BET). The new LAL reagent is

sustainably produced using recombinant technology; it is not based on raw

materials from animals, unlike traditional LAL reagents which are manufactured

using the blood harvested from horseshoe crabs. After years of research and

development, the Company has been able to bring a truly sustainable alternative

LAL reagent, designed to deliver consistent and reliable quantitation in all

BET applications requiring LAL reagents such as testing of water, injectable

drugs, vaccines and medical devices.

Video -

https://mma.prnewswire.com/media/1493537/ACC_PSNG_Launch_2_Flag_2021_04_12.mp4

Logo -

https://mma.prnewswire.com/media/1223081/Associates_of_Cape_Cod_Inc_Logo.jpg

Laboratory analysts can maintain the same test method, sample preparation, and

plate reader instrumentation used for traditional BET tests, because PyroSmart

NextGen(TM) reagent is a recombinant Cascade Reagent (rCR) and follows the same

enzymatic cascade pathway as traditional naturally sourced reagents.  The

advantage of this innovative product compared to existing single Recombinant

Factor C (rFC) products, is that PyroSmart NextGen(TM), is a direct replacement

for naturally sourced reagents and eliminates the need to change test methods

and purchase new specialized instrumentation as required by first generation

recombinant reagents.

"The launch of our full recombinant cascade reagent, PyroSmart NextGen(TM),

establishes a new gold standard in LAL reagent technology and provides an easy

to use, highly competitive, sustainable BET reagent option with the same high

quality and consistency clients expect from ACC products," commented A.J.

Meuse, PhD, ACC's President and CEO. "We were the first FDA-licensed LAL

reagent manufacturer, and we continue our pioneering efforts to be the first to

make a full recombinant cascade reagent available to the market."

Transitioning to the use of a new recombinant LAL reagent requires some level

of validation, irrespective of the article being tested.  ACC provides its

valued customers with comprehensive support, including established protocol

templates and access to ACC's knowledgeable and dedicated team of technical

experts, to facilitate the transition to a new reagent type.

Please contact ACC for more information about converting to PyroSmart

NextGen(TM).

For further information contact:

Vann Jones – Senior Manager, Marketing

Associates of Cape Cod, Inc.

East Falmouth, MA

USA

Phone: 888-395-2221

VJones@acciusa.com

www.acciusa.com

SOURCE  Associates of Cape Cod, Inc.